Gram-scale purification of dehydroevodiamine from Evodia rutaecarpa fruits, and a procedure for selective removal of quaternary indoloquinazoline alkaloids from Evodia extracts

详细信息    查看全文

• 作者：Anja Schramm ; Matthias Hamburger ; ^{matthias.hamburger@unibas.ch" class="auth_mail}
• 关键词：DHE ; dehydroevodiamine ; TCM ; traditional Chinese medicine
• 刊名：Fitoterapia
• 出版年：April, 2014
• 年：2014
• 卷：94
• 期：Complete
• 页码：127-133
• 全文大小：618 K

文摘

Dehydroevodiamine (DHE) is a major bioactive constituent in the traditional Chinese herbal drug Evodiae fructus (Wu zhu yu). The compound has been shown to possess pronounced cardiovascular and neuropharmacological activities in vitro and in vivo. For quality control purposes and follow-up studies assessing potential safety risks of DHE, we developed a simple and efficient two-step protocol for gram-scale purification of DHE. An alkaloidal fraction was obtained by cation-exchange solid phase extraction, and DHE and the minor alkaloid hortiamine were purified by isocratic preparative RP-HPLC. The DHE content in different commercial batches of Evodiae fructus, and in a series of commercially available Evodia-containing TCM products was assessed. A daily intake of up to mg amounts of DHE was calculated from recommended doses of these products. A method for the selective removal of quaternary indoloquinazoline alkaloids from Evodia extracts was developed.